HDAC9 and Alzheimer disease: The above studies have shown that HAT and HDAC inhibitors can increase the level of histone acetylation, enhance the expression of memory-related genes, prevent cognitive degeneration and Aβ protein deposition, affect abnormal tau phosphorylation, and reduce NFT formation, thus delaying the progression of AD, while deacetylase has the opposite effect.